Allied Market Research published a report, titled, “๐๐๐ง๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐ ๐๐ฅ๐๐ฌ๐ฌ (๐๐๐ญ๐ข๐ง๐จ๐ข๐๐ฌ, ๐๐ง๐ญ๐ข๐๐ข๐จ๐ญ๐ข๐๐ฌ, ๐๐๐ฅ๐ข๐๐ฒ๐ฅ๐ข๐ ๐๐๐ข๐, ๐๐๐ง๐ณ๐จ๐ฒ๐ฅ ๐๐๐ซ๐จ๐ฑ๐ข๐๐, ๐๐ง๐ ๐๐ญ๐ก๐๐ซ๐ฌ), ๐ ๐จ๐ซ๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง (๐๐จ๐ฉ๐ข๐๐๐ฅ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ ๐๐ง๐ ๐๐ซ๐๐ฅ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ), ๐๐ฒ๐ฉ๐ (๐๐ซ๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง ๐๐๐๐ข๐๐ข๐ง๐๐ฌ ๐๐ง๐ ๐๐ฏ๐๐ซ-๐๐ก๐-๐๐จ๐ฎ๐ง๐ญ๐๐ซ ๐๐๐๐ข๐๐ข๐ง๐๐ฌ), ๐๐๐ง๐ ๐๐ฒ๐ฉ๐ (๐๐จ๐ง-๐๐ง๐๐ฅ๐๐ฆ๐ฆ๐๐ญ๐จ๐ซ๐ฒ ๐๐๐ง๐ ๐๐ง๐ ๐๐ง๐๐ฅ๐๐ฆ๐ฆ๐๐ญ๐จ๐ซ๐ฒ ๐๐๐ง๐), ๐๐ง๐ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ (๐๐๐ญ๐๐ข๐ฅ ๐๐ญ๐จ๐ซ๐๐ฌ, ๐๐ก๐๐ซ๐ฆ๐๐๐ข๐๐ฌ & ๐๐ซ๐ฎ๐ ๐๐ญ๐จ๐ซ๐๐ฌ, ๐๐ง๐ ๐-๐๐จ๐ฆ๐ฆ๐๐ซ๐๐): ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐ง๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ, ๐๐๐๐-๐๐๐๐.” According to the report, the global Acne Medication Market Size was Valued at USD 11.86 billion in 2019 and is Anticipated to Garner USD 13.35 billion by 2027, registering a CAGR of 3.8% from 2020 to 2027.
This report provides a comprehensive overview of the Acne Medication Market, including an in-depth analysis of market trends, key segments, investment opportunities, value chain analysis, regional landscape, and competitive scenarios. It offers valuable insights for established market players, new entrants, investors, and other stakeholders to devise effective strategies and make informed decisions to enhance their market position. The report is a valuable resource for anyone seeking to gain a deeper understanding of the Acne Medication Market and its growth potential in the future.
Covid-19 scenario:
โข The majority of the dermatology clinic closed their services since the outbreak of Covid-19 and the number of hospitals and clinics is temporarily converted into Covid-19 centers.
โข After several governments imposed social distancing norms and lockdown across the country, people have shifted toward telemedicine to treat acne diseases.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/4356
Rise in prevalence of acne diseases, unhealthy urban lifestyle, and increase in focus toward good quality skin care products drive the growth of the global acne medication market. On the other hand, side effects associated with acne medications and presence of alternatives for acne treatment restrain the growth. Nevertheless, development of therapeutics with lesser side effects is expected to create multiple opportunities for the key players in the sector.
๐๐จ๐ฉ ๐๐๐ง๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข Pfizer Inc.
โข Johnson & Johnson
โข Sun Pharmaceutical Industries Limited
โข Teva Pharmaceutical Industries Ltd.
โข Mylan N.V.
โข Bausch Health Companies Inc.
โข GlaxoSmithKline Plc (GSK)
โข Galderma S.A
โข Mayne Pharma Group Limited
โข Almirall SA.
๐๐๐ง๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
Based on therapeutic class, the retinoid segment accounted for nearly one-third of the global acne medication market revenue in 2019 and is expected to rule the roost by 2027. The same segment would register the fastest CAGR of 4.6% throughout the forecast period. Retinoid are most effective for moderate to severe acne as it unblocks pores, allowing topical creams and gels to work better. This factor drives the growth of the segment.
Based on formulation, the topical medication segment contributed to more than four-fifths of the global acne medication market share in 2019 and is anticipated to lead the trail by the end of 2027. The same segment would also grow at the fastest CAGR of 3.9% till 2027. This is because topical formulations are less toxic and do not affect other organs.
Based on geography, North America generated the highest share in 2019, garnering nearly half of the global acne medication market, due to numerous developments related to acne therapeutics. Simultaneously, Asia-Pacific would manifest the fastest CAGR of 4.9% from 2020 to 2027, owing to increase in number of product launches, high demand for acne therapeutics, surge in healthcare expenditure, and rise in awareness about new developed therapeutics that can replace conventional acne treatment.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4356
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.